BN · rank #9 · 2026-09-11
EXENS
PARIS · EUR · $3.29B (USD)
The exact numbers the algorithm saw.
| Composite score Z-score blend of the factors below; drives the rank. | -0.39 |
|---|---|
| Forward revenue growth Consensus forward revenue growth. | +14.1% |
| Forward net margin Consensus forward net margin. | +6.2% |
| Net margin TTM Trailing twelve month net margin. | +6.0% |
| Margin expansion Forward minus trailing net margin (percentage points). | +0.2% |
| Forward PEG Forward P/E to growth. Below 1 is cheap for the growth. | — |
| Debt / FCF Net debt relative to free cash flow. Lower is safer. | 2.58× |
| Analyst upside Spread between the consensus 12m target and the current price. | +20.2% |
| Last EPS surprise Most recent reported EPS versus consensus. | — |
| Market cap (USD) | $3.29B |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
Exosens is a French photonics company that manufactures mission-critical electro-optical amplification, detection, and imaging systems for defense, nuclear, life sciences, and industrial control markets.
Rationale
The bottleneck-solver signal is valid because Exosens' specialized nuclear instrumentation addresses Small Modular Reactor (SMR) carbon-free power bottlenecks for AI data centers, while its multispectral cameras solve critical power grid surveillance bottlenecks.
Material risks
- 1The Detection & Imaging segment is a short-cycle business with only two to three months of lead-time visibility, exposing the company's AI nuclear and grid monitoring revenues to short-term corporate capex volatility.
- 2High leverage of 2.58x debt-to-FCF and the capital-intensive nature of its €20 million production capacity expansion plans could pressure margins if defense budget growth slows down.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 2 of 3 voted to proceed.